Page 2 - Brian Nyquist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A growing drug program is helping hospitals instead of the uninsured, kids and elderly it was meant to help, says Brian Nyquist.

Robert John “Bob” Nyquist, age 93 passed away peacefully on Sunday, March 13, 2022 in Waterview Shores Nursing Home in Two Harbors while battling cancer with his family by his side. He was a true fighter until the end. He was born in Two Harbors, MN in 1928 to John Oscar and Violet Nyquist. He graduated Two Harbors High School with the class of “46”. He served in the United States Army during the Korean conflict and when he returned back home he met the love of his life Marilyn Mattson at a dry dance in Duluth. Five years later they met again in Minneapolis and fell in love. They were ...

Jan. 27: Abigail Spanberger (D-VA-07) and Anthony Gonzalez (R-OH-16) yesterday introduced the Protecting Patient Access to Lifesaving COVID-19 Drugs Act, legislation that would expand access to lifesaving COVID-19 treatments by requiring private health insurance plans to cover the administration costs of monoclonal antibodies without cost-sharing. Authorized by the Food and Drug Administration in November 2020, monoclonal antibodies have proven to prevent COVID-19 infections and reduce COVID-19 related hospitalizations. The U.S. Department of Health and Human Services purchased 950,000 do...

Print By the time he tested positive for a coronavirus infection, Gary Herritz was feeling pretty sick. His scratchy throat had progressed to a dry cough, headache, joint pain and fever. A liver transplant recipient, he knew his compromised immune system made him vulnerable to a severe case of COVID-19. Herritz had read on Twitter about monoclonal antibody therapy, the type of treatment famously touted by Donald Trump after his release from Walter Reed National Military Medical Center. The Food and Drug Administration authorized its emergency use to keep high-risk COVID-19 patients out of th...

. (Tribune News Service) — By the time he tested positive for a coronavirus infection, Gary Herritz was feeling pretty sick. His scratchy throat had progressed to a dry cough, headache, joint pain and fever. A liver transplant recipient, he knew his compromised immune system made him vulnerable to a severe case of COVID-19. Herritz had read on Twitter about monoclonal antibody therapy, the type of treatment famously touted by Donald Trump after his release from Walter Reed National Military Medical Center. The Food and Drug Administration authorized its emergency use to keep high-r...